STOK
NASDAQ · Biotechnology
Stoke Therapeutics Inc
$33.40
-0.11 (-0.33%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+50.2% upside
Low Target
$29.72
Average Target
$50.17
High Target
$68.67
Current Price
$33.40
Current
$33.40
$33.40
Target
$50.17
$50.17
$29.72
$50.17 avg
$68.67
Scenario Analysis
Bear Case
$29.72
-11.0%
Low target
Base Case
$50.17
+50.2%
Avg target
Bull Case
$68.67
+105.6%
High target
Risk/Reward
9.6x
Highly favorable
Price in Context
52-Week High
$39.81
-16.1% from high
52-Week Low
$5.35
+524.3% from low
Target vs 52W High
$50.17
+26.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |